Emmessar Biotech & Nutrition Limited (BOM:524768)
India flag India · Delayed Price · Currency is INR
26.37
-1.43 (-5.14%)
At close: Feb 12, 2026

BOM:524768 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
3.167.55.044.7514.5
Depreciation & Amortization
0.980.980.940.920.58
Other Operating Activities
1.55-4.392.78-0.545.75
Change in Accounts Receivable
0.05-0.120.0226.97-26.84
Change in Inventory
-0.350.47-0.68-0.0110.82
Change in Accounts Payable
-0.060.09-0.22-4.75-3.08
Change in Other Net Operating Assets
-3.091.92-4.11-4.652.94
Operating Cash Flow
2.246.453.7622.74.68
Operating Cash Flow Growth
-65.28%71.34%-83.43%385.13%-54.60%
Capital Expenditures
---0.26-3.06-0.02
Investment in Securities
-6.92-9.9-7.79-24.58-1.14
Other Investing Activities
4.633.472.591.491.24
Investing Cash Flow
-2.3-6.44-5.46-26.140.08
Other Financing Activities
0.04----
Financing Cash Flow
0.04----
Net Cash Flow
-0.030.01-1.7-3.454.76
Free Cash Flow
2.246.453.519.644.66
Free Cash Flow Growth
-65.28%84.22%-82.19%321.44%-54.75%
Free Cash Flow Margin
10.48%31.57%13.91%110.78%5.51%
Free Cash Flow Per Share
0.451.290.703.930.93
Cash Interest Paid
0.01----
Cash Income Tax Paid
0.17-0.2-0.62-2.921
Levered Free Cash Flow
14.864.50.6816.642.33
Unlevered Free Cash Flow
14.874.50.6816.642.33
Change in Working Capital
-3.452.36-4.9917.57-16.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.